Everything below concerns Reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-04. Numbers and descriptions here follow the published literature rather than marketing material.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual descriptor; not a measure of purity |
| Solubility class | Freely soluble in water | Aqueous dissolution may require gentle mixing |
| Typical storage (powder) | −20 °C or below, desiccated | Protect from light and ambient moisture |
| Typical storage (solution) | 2–8 °C, short term | Freeze aliquots where longer holding is needed |
| Purity assessment | Reversed-phase HPLC, area percent | Values depend on column, gradient, and detection wavelength |
=== Metalloproteins === Metalloproteins are conjugated proteins that are characterized by having one or more metal ions attached to the protein as a prosthetic groups. These metal ions could be iron, zinc, copper, magnesium, etc., and these are very important to the biological functions and its protein activity. Metalloproteins are involved in a wide range processes from electron transfer to catalysis. Many enzymes are metalloproteins, since metal ions can act as cofactors in chemical reactions. For example, zinc ions can be associated with enzymes that are responsible for gene expression. Moreover, metalloproteins containing iron often are involved in oxygen transport and redox reactions. In this way, the presence of metal ions allows these proteins to perform certain tasks that would not be possible with amino acids alone.
A nuclear localization signal (NLS) is a target peptide that directs proteins to the nucleus and is often a unit consisting of five basic, positively charged amino acids. The NLS normally is located anywhere on the peptide chain. A nuclear export signal (NES) is a target peptide that directs proteins from the nucleus back to the cytosol. It often consists of several hydrophobic amino acids (often leucine) interspaced by 2-3 other amino acids. Many proteins are known to constantly shuttle between the cytosol and nucleus and these contain both NESs and NLSs.
Acne necrotica Acquired generalized hypertrichosis (acquired hypertrichosis lanuginosa, hypertrichosis lanuginosa acquisita) Acquired perforating dermatosis (acquired perforating collagenosis) Acrokeratosis paraneoplastica of Bazex (acrokeratosis neoplastica, Bazex syndrome) Acroosteolysis Acute paronychia Alopecia areata Alopecia neoplastica Anagen effluvium Androgenic alopecia (androgenetic alopecia) Anhidrosis (hypohidrosis) Anonychia Apparent leukonychia Beau's lines Blue nails Bromidrosis (apocrine bromhidrosis, fetid sweat, malodorous sweating, osmidrosis) Bubble hair deformity Central centrifugal cicatricial alopecia (follicular degeneration syndrome, pseudopelade of the central scalp) Chevron nail (herringbone nail) Chromhidrosis (colored sweat) Chronic paronychia Cicatricial alopecia Clubbing (drumstick fingers, Hippocratic fingers, watch-glass nails) Congenital onychodysplasia of the index fingers Disseminate and recurrent infundibulofolliculitis Erosive pustular dermatitis of the scalp (erosive pustular dermatosis of the scalp) Erythromelanosis follicularis faciei et colli Folliculitis decalvans Folliculitis nares perforans Fox–Fordyce disease Frontal fibrosing alopecia Generalized congenital hypertrichosis (congenital hypertrichosis lanuginosa) Generalized hyperhidrosis Graham-Little syndrome Granulosis rubra nasi Green nails Gustatory hyperhidrosis Hair casts (pseudonits) Hair follicle nevus (vellus hamartoma) Hairy palms and soles Half and half nails (Lindsay's nails) Hangnail Hapalonychia Hematidrosis Hirsutism Hook nail Hot comb alopecia Hypertrichosis cubiti (hairy elbow syndrome) Hypertrichosis simplex of the scalp Intermittent hair–follicle dystrophy Keratosis pilaris atrophicans Kinking hair (acquired progressive kinking) Koenen's tumor (Koenen's periungual fibroma, periungual fibroma) Koilonychia (spoon nails) Kyrle disease Leukonychia (white nails) Lichen planopilaris (acuminatus, follicular lichen planus, lichen planus follicularis, peripilaris) Lichen planus of the nails Lichen spinulosus (keratosis spinulosa) Lipedematous alopecia (lipedematous scalp) Localized acquired hypertrichosis Localized congenital hypertrichosis Longitudinal erythronychia Longitudinal melanonychia Loose anagen syndrome (loose anagen hair syndrome) Lupus erythematosus Madarosis Malalignment of the nail plate Male-pattern baldness Marie–Unna hereditary hypotrichosis (Marie–Unna hypotrichosis) Median nail dystrophy (dystrophia unguis mediana canaliformis, median canaliform dystrophy of Heller, solenonychia) Mees' lines Melanonychia Menkes kinky hair syndrome (kinky hair disease, Menkes disease) Monilethrix (beaded hair) Muehrcke's nails (Muehrcke's lines) Nail–patella syndrome (Fong syndrome, hereditary osteoonychodysplasia, HOOD syndrome) Neoplasms of the nailbed Nevoid hypertrichosis Noncicatricial alopecia Onychauxis Onychoatrophy Onychocryptosis (ingrown nail, unguis incarnatus) Onychogryphosis (ram's horn nails) Onycholysis Onychomadesis Onychomatricoma Onychophagia (nail biting) Onychophosis Onychoptosis defluvium (alopecia unguium) Onychorrhexis (brittle nails) Onychoschizia Onychotillomania Ophiasis Palmoplantar hyperhidrosis (emotional hyperhidrosis) Parakeratosis pustulosa Patterned acquired hypertrichosis Perforating folliculitis Pili annulati (ringed hair) Pili bifurcati Pili multigemini Pili pseudoannulati (pseudo pili annulati) Pili torti (twisted hairs) Pincer nails (omega nails, trumpet nails) Pityriasis amiantacea (tinea amiantacea) Platonychia Plica neuropathica (felted hair) Plummer's nail Premature greying of hair Prepubertal hypertrichosis Pressure alopecia (postoperative alopecia, pressure-induced alopecia) Pseudofolliculitis barbae (barber's itch, folliculitis barbae traumatica, razor bumps, scarring pseudofolliculitis of the beard, shave bumps) Pseudopelade of Brocq (alopecia cicatrisata) Psoriatic nails Pterygium inversum unguis (pterygium inversus unguis, ventral pterygium) Pterygium unguis (dorsal pterygium) Purpura of the nail bed Racquet nail (brachyonychia, nail en raquette, racquet thumb) Recurrent palmoplantar hidradenitis (idiopathic palmoplantar hidradenitis, idiopathic plantar hidradenitis, painful plantar erythema, palmoplantar eccrine hidradenitis, plantar panniculitis) Red lunulae Ross' syndrome Rubinstein–Taybi syndrome Setleis syndrome Shell nail syndrome Short anagen syndrome Splinter hemorrhage Spotted lunulae Staining of the nail plate Subungual hematoma Telogen effluvium Terry's nails Traction alopecia Traumatic alopecia Traumatic anserine folliculosis Triangular alopecia (temporal alopecia, temporal triangular alopecia) Trichomegaly Trichomycosis axillaris Trichorrhexis invaginata (bamboo hair) Trichorrhexis nodosa Trichostasis spinulosa Tufted folliculitis Tumor alopecia Twenty-nail dystrophy (sandpapered nails, trachyonychia) Uncombable hair syndrome (cheveux incoiffable, pili trianguli et canaliculi, spun-glass hair) Wooly hair nevus (woolly hair nevus) X-linked hypertrichosis
Sources: en.wikipedia.org
Despite protests against a plan to incinerate the hazardous waste in Pithampur, on January 1, 2025, an overnight caravan of a dozen semi trucks with police escort, a quick-response team, fire engines and ambulances delivered 377 tons of waste to Pithampur Industrial Area for incineration. Despite promises that the several hundred tons of toxic waste will be processed safely and responsibly, protests continued in Pithampur.
== Applications == The highest selling transdermal patch in the United States is the nicotine patch, which releases nicotine in controlled doses to help with cessation of tobacco smoking. The first commercially available vapour patch to reduce smoking was approved in Europe in 2007. Two opioid medications used to provide round-the-clock relief for severe pain are often prescribed in patch form, fentanyl CII (marketed as Duragesic) and buprenorphine CIII (marketed as BuTrans). Hormonal patches: Estrogen patches are sometimes prescribed to treat menopausal symptoms (as well as post-menopausal osteoporosis) and to transgender women as a type of hormone replacement therapy. Contraceptive patches (marketed as Ortho Evra or Evra) and Testosterone CIII patches for both men (Androderm) and women (Intrinsa). Nitroglycerin patches are sometimes prescribed for the treatment of angina in lieu of sublingual pills. Transdermal scopolamine is commonly used as a treatment for motion sickness. The anti-hypertensive drug clonidine is available in transdermal patch form. Emsam, a transdermal form of the MAOI selegiline, became the first transdermal delivery agent for an antidepressant approved for use in the U.S. in March 2006. Daytrana, the first methylphenidate transdermal delivery system for the treatment of attention deficit hyperactivity disorder (ADHD), was approved by the FDA in April 2006. Secuado, a transdermal form of the atypical antipsychotic asenapine, was approved by the FDA in October 2019.
=== Project management === There are two main sources of new research projects, namely ideas originating from the researchers themselves ("supply push") and those coming from customers ("demand pull"). Ideas for new processes typically originate from researchers, while ideas for new products from customers, respectively customer contacts. Especially in custom manufacturing, "demand pull" prevails industrial reality. The "new product committee" is the body of choice for evaluating new and monitoring ongoing research activities. It evaluates all new product ideas, decides whether a new product idea should be taken up in research, reassesses a project at regular intervals and decides also on the abandonment of a project, once it becomes evident that the objectives cannot be reached. In a typical project, the overall responsibility for the economic and technical success lies with the project champion. He is assisted by the project manager, who is responsible for the technical success. In custom manufacturing, a typical project starts with the acceptance of the product idea, which originates mainly from business development, by the new product committee, followed by the preparation of a laboratory process, and ends with the successful completion of demonstration runs on industrial scale and the signature of a multiyear supply contract. The input from the customer is contained in the "technology package".
=== Pharmacokinetics === Following oral administration, tapentadol typically provides onset of analgesia within 32 minutes, with effects lasting approximately 4 to 6 hours. Approximately 32% of an oral dose of tapentadol escapes first-pass metabolism in the liver, entering systemic circulation to exert pharmacological effects on both the central nervous system (CNS) and peripheral nervous system (PNS). The free base conversion factor for tapentadol hydrochloride is 0.86. Food intake has a minor impact on the drug's peak plasma concentration: increasing it by approximately 8% for immediate-release (IR) and 18% for extended-release (ER) formulations. These differences are not clinically significant, and tapentadol may be taken with or without food. Tapentadol displays dose-dependent plasma concentrations; however, higher doses (e.g., 250 mg) may produce disproportionately elevated Cmax values relative to lower doses, suggesting non-linear pharmacokinetics at higher concentrations. In receptor binding studies, tapentadol demonstrated a Ki of 60 nM for cloned human μ-opioid receptors, with strong agonist activity comparable to morphine, as measured by [35S]GTPγS binding assays. Its inhibitory effect on norepinephrine reuptake (Ki = 480 nM) complements its opioid activity, while its weak serotonergic effects distinguish it from dual-acting agents like tramadol. In vitro studies using human tissue indicate that tapentadol has approximately one-third the binding affinity of morphine for the human μ-opioid receptor, reflecting its comparatively lower opioid potency.
Sources: en.wikipedia.org
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.
There is no single agreed limit, and laboratory practice varies widely. Refrigeration slows degradation, and freezing aliquots is often described for longer holding. Any visible cloudiness or precipitate indicates the solution should be discarded.
Mass spectrometry provides the most direct confirmation through molecular mass. Reversed-phase chromatography supports purity assessment, and peptide mapping or amino acid analysis can corroborate sequence. No single method establishes both purity and identity on its own.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.